Metropolitan Life Insurance Company (MetLife)’s Health Catalyst HCAT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,051	Closed	-$23K	–	918
2024 Q1	$23K	Hold	3,051	–	–	﹤0.01%	1789
2023 Q4	$28.3K	Hold	3,051	–	–	﹤0.01%	1759
2023 Q3	$30.9K	Hold	3,051	–	–	﹤0.01%	1665
2023 Q2	$38.1K	Hold	3,051	–	–	﹤0.01%	1589
2023 Q1	$35.6K	Sell	3,051 -212	-6%	-$2.7K	﹤0.01%	1575
2022 Q4	$34.7K	Hold	3,263	–	–	﹤0.01%	1698
2022 Q3	$31.7K	Hold	3,263	–	–	﹤0.01%	1765
2022 Q2	$47.3K	Hold	3,263	–	–	﹤0.01%	1545
2022 Q1	$85.3K	Sell	3,263 -9,967	-75%	-$283K	﹤0.01%	1295
2021 Q4	$524K	Hold	13,230	–	–	0.01%	1387
2021 Q3	$662K	Buy	13,230 +867	+7%	+$47.3K	0.01%	1260
2021 Q2	$686K	Buy	12,363 +2,616	+27%	+$139K	0.01%	1304
2021 Q1	$456K	Sell	9,747 -365	-4%	-$17.7K	0.01%	1483
2020 Q4	$440K	Hold	10,112	–	–	0.01%	1441
2020 Q3	$370K	Hold	10,112	–	–	0.01%	1410
2020 Q2	$295K	Buy	10,112 +4,007	+66%	+$111K	0.01%	1554
2020 Q1	$160K	Buy	6,105 +3,347	+121%	+$102K	﹤0.01%	1727
2019 Q4	$95.7K	Sell	2,758 -2,316	-46%	-$76.7K	﹤0.01%	2362
2019 Q3	$161K	Buy	+5,074	New	+$200K	﹤0.01%	2030

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s HCAT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 3,051 shares — an estimated $23K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HCAT in Q3 2019 and held it in 19 quarters. The position peaked at $686K in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,051 Health Catalyst shares in Q2 2024, an estimated $23K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Health Catalyst in Q3 2019 and held it in 19 quarters.
Metropolitan Life Insurance Company (MetLife)'s Health Catalyst position peaked at $686K in Q2 2021.
161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.